Articles published by ICON plc
ICON plc Schedules Third Quarter 2023 Earnings Conference Call
September 21, 2023
From ICON plc
Via Business Wire
Tickers
ICLR
ICON Releases Expanded End-to-end Clinical Trial Tokenisation Solution
September 20, 2023
From ICON plc
Via Business Wire
Tickers
ICLR
BARDA Partners With ICON to Execute Next Generation COVID-19 Vaccines Clinical Trial
September 13, 2023
From ICON plc
Via Business Wire
Tickers
ICLR
ICON plc to Present at the Baird Global Healthcare Conference
September 06, 2023
From ICON plc
Via Business Wire
Tickers
ICLR
ICON plc to Attend Upcoming Investor Conferences
May 31, 2023
From ICON plc
Via Business Wire
Tickers
ICLR
ICON releases its 2022 ICON Cares ESG Report
May 16, 2023
From ICON plc
Via Business Wire
Tickers
ICLR
ICON plc to Present at Upcoming Investor Conferences
February 27, 2023
From ICON plc
Via Business Wire
Tickers
ICLR
ICON Reports Fourth Quarter and Full Year 2022 Results
February 22, 2023
From ICON plc
Via Business Wire
Tickers
ICLR
ICON plc Schedules Fourth Quarter 2022 Earnings Conference Call
January 26, 2023
From ICON plc
Via Business Wire
Tickers
ICLR
ICON Issues Financial Guidance for Full Year 2023
January 10, 2023
From ICON plc
Via Business Wire
Tickers
ICLR
ICON plc to Present at the 2022 Evercore ISI HealthCONx Conference
November 23, 2022
From ICON plc
Via Business Wire
Tickers
ICLR
ICON Reports Third Quarter 2022 Results
November 02, 2022
From ICON plc
Via Business Wire
Tickers
ICLR
ICON selected by BARDA to conduct anthrax vaccine clinical trial
October 06, 2022
From ICON plc
Via Business Wire
Tickers
ICLR
ICON plc Schedules Third Quarter 2022 Earnings Conference Call
September 26, 2022
From ICON plc
Via Business Wire
Tickers
ICLR
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.